Mark L. Fuerst is a freelance health and medical writer for ConsultantLive, Rheumatology Network, Psychiatric Times, and other UBM publications. He writes about rheumatology, psychiatry, neurology, endocrinology, oncology, and men’s health.
Online Calculator Personalizes PrEP Initiation
A new Web-based algorithm uses more refined criteria to better identify PrEP candidates at highest risk for HIV infection.
Older Adults and HIV: Don't Underestimate Risk
One in 6 new HIV diagnoses occurs in people over age 50. Are you routinely asking your older patients about their sexual history?
Mannitol Test for Asthma Presents Challenges
The test should not be used alone to screen for asthma in asymptomatic young persons outside of the clinic.
Insomnia Common with Asthma
The combination results in worse asthma control and a variety of health and quality of life issues.
Direct-acting Antivirals Treat HIV/HCV Coinfection in Real-world Study
Twelve-week viral eradication rates were high in patients coinfected with HCV and HIV, particularly in those without advanced cirrhosis.
Advanced Cirrhosis Patients Respond to DAAs in Real-world Study
High sustained virologic response rates were seen among patients with decompensated cirrhosis in European compassionate care cohort.
Young Urban Asthma Patients Exhibit Unique Features
Severe asthma symptoms but low allergy and inflammation levels may mean poor response to guideline-based therapy.
Teens with Asthma More Likely to Smoke Cigarettes
Study: Among adolescents age 13-19 years, those with asthma were twice as likely to smoke as their healthy counterparts. Solutions?
DAA Combination Confirmed Highly Effective Against HCV in Real-world Setting
Sustained virologic response was seen in 99% of subjects, reflecting rates seen in pre-registration studies. Adverse events were mild.
DAAs Cost-effective in HCV Patients with Advanced Fibrosis
A modeling study compared health benefits and costs of all currently licensed treatments, both singly and in sequential therapy of up to 3 lines.
By clicking Accept, you agree to become a member of the UBM Medica Community.